These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A, B, H antigen detectability in normal and neoplastic urothelium. Influence of methodologic factors. Limas C, Lange P. Cancer; 1982 Jun 15; 49(12):2476-84. PubMed ID: 7074564 [Abstract] [Full Text] [Related]
3. T-antigen in normal and neoplastic urothelium. Limas C, Lange P. Cancer; 1986 Sep 15; 58(6):1236-45. PubMed ID: 3742450 [Abstract] [Full Text] [Related]
5. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course. Limas C, Lange P, Fraley EE, Vessella RL. Cancer; 1979 Dec 15; 44(6):2099-107. PubMed ID: 509389 [Abstract] [Full Text] [Related]
8. Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma. Sadoughi N, Mlsna J, Guinan P, Rubenstone A. Urology; 1982 Aug 15; 20(2):143-6. PubMed ID: 7051508 [Abstract] [Full Text] [Related]
9. [Study of the Thomsen-Friedenreich antigen in bladder tumors]. Fukatsu H, Yamada H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Nishikawa E, Yamada Y. Hinyokika Kiyo; 1988 Feb 15; 34(2):260-7. PubMed ID: 3376818 [Abstract] [Full Text] [Related]
10. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder]. Igawa M. Hinyokika Kiyo; 1986 Nov 15; 32(11):1663-76. PubMed ID: 3825815 [Abstract] [Full Text] [Related]
11. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach. Sadoughi N, Rubenstone A, Mlsna J, Davidsohn I. J Urol; 1980 Jan 15; 123(1):19-21. PubMed ID: 6985978 [Abstract] [Full Text] [Related]
12. Thomsen-Friedenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence. Ohoka H, Shinomiya H, Yokoyama M, Ochi K, Takeuchi M, Utsumi S. Urol Res; 1985 Jan 15; 13(2):47-50. PubMed ID: 4012935 [Abstract] [Full Text] [Related]
13. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)]. Gelabert Mas A, Corominas J, Arango O. Actas Urol Esp; 1988 Jan 15; 12(3):248-53. PubMed ID: 3177059 [No Abstract] [Full Text] [Related]
14. The cell surface antigen A, B or O(H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report. Bergman S, Javadpour N. J Urol; 1978 Jan 15; 119(1):49-51. PubMed ID: 621814 [Abstract] [Full Text] [Related]
15. The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder. Young AK, Hammond E, Middleton AW. J Urol; 1979 Oct 15; 122(4):462-4. PubMed ID: 480485 [Abstract] [Full Text] [Related]
18. Tissue blood-group antigens and prognosis in low stage transitional cell carcinoma of the bladder. Lange PH, Limas C, Fraley EE. J Urol; 1978 Jan 15; 119(1):52-5. PubMed ID: 621815 [Abstract] [Full Text] [Related]
19. Blood group ABH-related antigens in normal and malignant bladder urothelium: possible structural basis for the deletion of type-2 chain ABH antigens in invasive carcinomas. Orntoft TF, Wolf H, Clausen H, Dabelsteen E, Hakomori S. Int J Cancer; 1989 May 15; 43(5):774-80. PubMed ID: 2497072 [Abstract] [Full Text] [Related]